Spencer Kobren Interviews Replicel's CEO Concerning Latest Clinical Trial Results

[Sogeking]

The trials results are nothing spectacular actually they are kind of disappointing.
Especially when we know they injected high dosage of DSC cells into the test area.
However if they go back to the drawing board, research this some more than who knows. We will see what time brings us. I hope they succeed.
But our knowledge of hair follicles is still too meager, there are perhaps some crucial growth factors or fillcle parts missing for this to work even better.